Equity Transactions (Tables)

3 Months Ended

Sep. 30, 2020

Disclosure Stock Options Tables Abstract

Schedule of Stock Option Issued

The following table summarizes the activity relating to the Company’s stock options for the three months ended September 30, 2020:

	Options			Weighted-Average Exercise Price		Weighted Remaining Average Contractual Term		Aggregate Intrinsic Value
Outstanding at June 30, 2020		60,400			11.06		4.2		352,600
Granted		—			—		—		—
Options Exercised or Forfeited		(3,200	)		4.76		—		—
Outstanding at September 30, 2020		57,200		$	11.41		3.9	$	133,848
Exercisable at  September 30, 2020		57,200		$	11.41		3.9	$	133,848

Schedule of option outstanding and exercisable by exercise price

The following is a summary of stock options outstanding and exercisable by exercise price as of September 30, 2020:

Exercise Price		Outstanding		Weighted Average Contract Life		Exercisable
$	2.80		7,200		4.3		7,200
$	3.75		4,800		3.3		4,800
$	6.25		1,600		3.1		1,600
$	7.50		25,600		5.4		25,600
$	8.75		1,600		3.5		1,600
$	12.50		4,000		2.3		4,000
$	25.00		1,600		2.0		1,600
$	26.25		4,400		1.6		4,400
$	27.50		800		1.5		800
$	28.75		1,600		1.8		1,600
$	31.25		4,000		1.1		4,000

Schedule of Warrants Issued

The following table summarizes the warrants activity during the three months ended September 30, 2020:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Life (Years)		Aggregate Intrinsic Value
Outstanding and exercisable at June 30, 2020		1,374,667		$	7.72		4.2	$	13,799,331
Granted		293,248		$	6.61		5.0	$	—
Expired		—		$	—		—	$	—
Exercised - Acuitas		(1,453,250	)	$	4.00		—	$	—
Outstanding and exercisable at September 30, 2020		214,665		$	10.87		4.1	$	803,365